Research interests include Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Cancer Research and Treatments, and T-cell and B-cell Immunology.
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
Journal for ImmunoTherapy of Cancer2019cited by 177position: middledoi